{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:59Z","timestamp":1789538819287,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>\n                    Digital papillary adenocarcinoma (DPA) is a rare malignant sweat gland tumor affecting fingers and toes most commonly. Human papillomavirus type 42 (HPV42), a low-risk HPV type, is an important diagnostic criterion. No uniform mutational signature has been detected in DPA except for\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    mutations encoding p.V600E in small case series and in single case reports. The aim of this study was to add to the data on the prevalence of low-risk HPV\/HPV42 detection and BRAF-VE1 immunohistochemistry in digital papillary adenocarcinoma. H and E-stained sections and immunohistochemistry for S100, SOX10, SMA, p63\/p40, CK7, CK5\/6, YAP1, and BRAF-VE1 were reviewed, and in situ hybridization (ISH) for low-risk HPV (including HPV42) or specifically HPV42 was performed. Clinical follow-up was obtained from patient records. Twenty-eight tumors were included and presented on the fingers (23), feet (4), and vulva (1) with a median size of 1.5\u00a0cm. The patient age ranged from 11 to 88 years (median: 49.5; M:F=6:1). Histopathologically, digital papillary adenocarcinomas presented as multinodular, poorly- or well-circumscribed tumors in the dermis and subcutaneous tissue, with solid, cystic, and papillary growth patterns. Cytologic atypia was mild to moderate. All tumors were positive for low-risk HPV and\/or HPV42. BRAF-VE1 immunohistochemistry was negative in all tumors. Two patients developed distant metastases; all other patients were alive without recurrence (median follow-up: 46.5\u00a0mo, range: 5 to 192\u00a0mo). In conclusion, this study does not support the pathogenic role of\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    p.V600E in digital papillary adenocarcinoma but confirms low-risk HPV\/HPV42 infection as the only driver in all tumors.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002588","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:00:10Z","timestamp":1784008810000},"page":"1166-1173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological Characterization of Digital Papillary Adenocarcinoma With Emphasis on Low-risk Human Papillomavirus In Situ Hybridization and BRAF-VE1 Immunohistochemistry"],"prefix":"10.1097","volume":"50","author":[{"given":"Daniel S.","family":"Alt","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Hrycaj","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Warren","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Plotzke","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May P.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus J.","family":"Busam","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brenn","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-2393","authenticated-orcid":false,"given":"Katharina","family":"Wiedemeyer","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/DSS.0000000000004722","article-title":"Digital papillary adenocarcinoma: an updated review of epidemiology, pathogenesis, and management","volume":"51","author":"Joshi","year":"2025","journal-title":"Dermatol Surg"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/ced\/llae317","article-title":"Epidemiology, survival and risk of subsequent primary malignancies in patients with digital papillary adenocarcinoma: a retrospective study of 213 patients in the Surveillance, Epidemiology, and End Results Program","volume":"49","author":"Joshi","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ced\/llae203","article-title":"National epidemiology of digital papillary adenocarcinoma in England 2013-2020: a population-based registry study","volume":"49","author":"Andrew","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0560.1987.tb00488.x","article-title":"Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations","volume":"14","author":"Kao","year":"1987","journal-title":"J Cutan Pathol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/PAS.0b013e31826320ec","article-title":"Cutaneous digital papillary adenocarcinoma: a clinicopathological study of 31 cases of a rare neoplasm with new observations","volume":"36","author":"Suchak","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.path.2017.01.010","article-title":"Update on malignant sweat gland tumors","volume":"10","author":"van der Horst","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaad.2017.02.028","article-title":"Aggressive digital papillary adenocarcinoma: a clinicopathological study of 19 cases","volume":"77","author":"Weingertner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PAS.0000000000000547","article-title":"\u201cApocrine hidrocystoma and cystadenoma\u201d-like tumor of the digits or toes: a potential diagnostic pitfall of digital papillary adenocarcinoma","volume":"40","author":"Molina-Ruiz","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0000000000002096","article-title":"Digital papillary adenocarcinoma in nonacral skin: clinicopathological and genetic characterization of 5 cases","volume":"47","author":"Kervarrec","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/DAD.0000000000003154","article-title":"Digital papillary adenocarcinoma of the vulva","volume":"48","author":"Fleming","year":"2026","journal-title":"Am J Dermatopathol"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cup.14386","article-title":"Two distinct pathogenic pathways of digital papillary adenocarcinoma: BRAF mutation or low-risk HPV infection","volume":"50","author":"Bui","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/PAT.0b013e32835af778","article-title":"Digital papillary adenocarcinoma: a tumor that should be considered in the differential diagnosis of neoplasms involving the digits","volume":"45","author":"Scolyer","year":"2013","journal-title":"Pathology"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/s41379-022-01094-8","article-title":"Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites","volume":"35","author":"Vanderbilt","year":"2022","journal-title":"Mod Pathol"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2159-8290.CD-22-0489","article-title":"Human papillomavirus 42 drives digital papillary adenocarcinoma and elicits a germ cell-like program conserved in HPV-positive cancers","volume":"13","author":"Leiendecker","year":"2023","journal-title":"Cancer Discov"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/cup.14430","article-title":"Acral BRAF-mutated tubular adenoma should be distinguished from HPV42-related digital papillary adenocarcinoma","volume":"50","author":"Kervarrec","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/dermatopathology11040037","article-title":"Digital papillary adenocarcinoma is HPV-42-associated and BRAFV600E negative: perspectives for diagnostic practice","volume":"11","author":"Dege","year":"2024","journal-title":"Dermatopathology (Basel)"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/DAD.0000000000001694","article-title":"A case report of papillary digital adenocarcinoma with BRAFV600E mutation and quantified mutational burden","volume":"43","author":"Trager","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anndiagpath.2015.08.002","article-title":"Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma","volume":"19","author":"Bell","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/dermatopathology11030018","article-title":"Digital papillary adenocarcinoma: the detection of low-risk human papillomaviruses and the BRAF p.V600E mutation in a subset of cases","volume":"11","author":"Chen","year":"2024","journal-title":"Dermatopathology (Basel)"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/DAD.0000000000003065","article-title":"Retrospective analysis of the utility of polymerase chain reaction-reverse sequence-specific oligonucleotide (GENOSEARCH HPV31) and human papillomavirus immunohistochemistry (BSB-66) in the diagnosis of digital papillary adenocarcinoma","volume":"47","author":"Hiraki","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jmoldx.2022.01.011","article-title":"Defining novel DNA virus-tumor associations and genomic correlates using prospective clinical tumor\/normal matched sequencing data","volume":"24","author":"Vanderbilt","year":"2022","journal-title":"J Mol Diagn"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/cup.14782","article-title":"Genomic and transcriptomic profiling of digital papillary adenocarcinomas reveals alterations in matrix remodeling and metabolic genes","volume":"52","author":"Bayraktar","year":"2025","journal-title":"J Cutan Pathol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/DSS.0000000000005005","article-title":"Digital papillary carcinoma: a literature review of epidemiology, management strategies, and patient outcomes","volume":"52","author":"Liu","year":"2026","journal-title":"Dermatol Surg"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00000478-200006000-00002","article-title":"Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited)","volume":"24","author":"Duke","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/path.1711600106","article-title":"S100 protein in human mammary tissue-immunoreactivity in breast carcinoma, including Paget disease of the nipple, and value as a marker of myoepithelial cells","volume":"160","author":"Gillett","year":"1990","journal-title":"J Pathol"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2017.12.002","article-title":"BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin","volume":"73","author":"Liau","year":"2018","journal-title":"Hum Pathol"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1172\/JCI126185","article-title":"Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma","volume":"129","author":"Sekine","year":"2019","journal-title":"J Clin Invest"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/DAD.0000000000002276","article-title":"MAML2 gene rearrangement occurs in nearly all hidradenomas: a reappraisal in a series of 20 cases","volume":"44","author":"Russell-Goldman","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/his.15023","article-title":"Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update","volume":"84","author":"Kervarrec","year":"2024","journal-title":"Histopathology"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/PAS.0000000000002420","article-title":"HPV42: a common low-risk HPV type associated with distinctive cervicovaginal and cutaneous neoplasia","volume":"49","author":"Talia","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/DAD.0000000000001393","article-title":"Differential expression of PLAG1 in apocrine and eccrine cutaneous mixed tumors: evidence for distinct molecular pathogenesis","volume":"42","author":"Russell-Goldman","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00428-024-03811-x","article-title":"Molecular analysis of apocrine mixed tumors and cutaneous myoepitheliomas: a comparative study confirming a continuous spectrum of one entity with near-ubiquitous PLAG1 and rare mutually exclusive HMGA2 gene rearrangements","volume":"486","author":"Mansour","year":"2025","journal-title":"Virchows Arch"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"100430","DOI":"10.1016\/j.modpat.2024.100430","article-title":"SOX10-internal tandem duplications and PLAG1 or HMGA2 fusions segregate eccrine-type and apocrine-type cutaneous mixed tumors","volume":"37","author":"Macagno","year":"2024","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:00:25Z","timestamp":1789538425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002588","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"2026-05-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}